Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Zeo ScientifiX's free cash flow for the twelve months ending Oct 31, 2025 was -$741.00K. For fiscal 2025 it was -$741.00K. The highest annual figure on record is -$448.25K in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$741.00K | – |
| FY2023 | Oct 31, 2023 | -$2.22M | – |
| FY2022 | Oct 31, 2022 | -$3.99M | – |
| FY2021 | Oct 31, 2021 | -$3.11M | – |
| FY2020 | Oct 31, 2020 | -$1.95M | – |
| FY2019 | Oct 31, 2019 | -$598.19K | – |
| FY2018 | Oct 31, 2018 | -$516.57K | – |
| FY2017 | Oct 31, 2017 | -$926.66K | – |
| FY2016 | Oct 31, 2016 | -$574.50K | – |
| FY2015 | Oct 31, 2015 | -$448.25K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$202.00K | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$485.00K | – |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$383.00K | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $215.00K | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$468.00K | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | -$2.07M | – |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | -$915.78K | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$293.85K | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | -$715.13K | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | -$759.36K | – |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | -$681.45K | – |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | -$838.91K | – |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | -$412.67K | – |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | -$393.66K | – |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | -$305.96K | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | -$192.89K | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | -$127.69K | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | -$147.11K | -505.8% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | -$130.34K | – |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | -$173.28K | – |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | -$65.85K | – |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $36.26K | – |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | -$159.86K | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | -$754.74K | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | -$48.32K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | -$340.81K | – |
See a number that looks wrong?